Vantage Aminos · Research
Verification methods, handling protocols, and compound documentation, written for researchers. Research use only.
Retatrutide: What the Research Shows Retatrutide is a synthetic triple receptor agonist with activity at the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon receptor (GCGR). It is an investigational compound, is not approved by the FDA for any use, and appears in the literature under the development designation LY3437943. […]
Tirzepatide: What the Research Shows Tirzepatide is a synthetic dual agonist with activity at both the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is the reference dual-incretin construct in the current literature. Structurally it is a 39-amino-acid peptide built on a GIP backbone with substitutions that confer GLP-1R activity, plus […]
Semaglutide: What the Research Shows Semaglutide is an independently verified agonist at the glucagon-like peptide-1 receptor (GLP-1R). It is one of the most widely referenced incretin research compounds in the current literature, and it is the single-receptor baseline against which the dual- and triple-agonist constructs are usually compared. Structurally it is a 31-amino-acid analog of […]
On July 23 and 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee reviewed seven peptides for the Section 503A Bulks List and recommended six of them. The committee voted against the recommendation of the FDA’s own multidisciplinary review team, which had advised against all seven. Coverage since has run from “the FDA approved BPC-157” to […]
A peptide is a molecule composed of two or more amino acids linked together by peptide bonds. It is the fundamental unit of protein chemistry and the subject of a large body of preclinical and biochemical research. Understanding what a peptide is, and how it differs from related molecule types, is useful context for anyone […]
Peptides have been at the center of biochemistry for over a century. The field’s key milestones run from the first laboratory synthesis of a peptide bond to the automation of peptide production that now supplies research compounds worldwide. 1902: The First Peptide Bond The concept of the peptide bond, the covalent link between amino acids, […]
The following glossary covers the most common terms encountered when reading about research peptides, COAs, and analytical testing. Definitions are framed for research contexts only. Core Chemistry Terms Amino acid The monomer unit from which peptides and proteins are built. Twenty standard amino acids are used by biology; each has an amino group (-NH₂), a […]
Semax is a synthetic heptapeptide (seven amino acids) structurally based on the ACTH(4-7) fragment of adrenocorticotropic hormone, with a Pro-Gly-Pro extension that increases its stability against enzymatic degradation. It is studied in preclinical research as a melanocortin-fragment analog and tool compound for investigating neurochemistry in animal and cell-culture research models. Semax is a fully synthetic […]
How to Vet a Research Peptide Vendor The research peptide market is uneven. Quality, documentation, and business practices vary widely between suppliers, and the burden of verification falls on the buyer. This guide outlines the criteria a research buyer can use to evaluate a vendor before placing an order. 1. A batch-specific Certificate of Analysis […]
Tesofensine vs 5-Amino-1MQ: How the Research Compares Tesofensine and 5-Amino-1MQ are both studied in metabolic research models, but they act through entirely different mechanisms: central monoamine reuptake versus a metabolic enzyme. At a glance Property Tesofensine 5-Amino-1MQ Class Triple monoamine reuptake inhibitor Small-molecule NNMT inhibitor Primary research target DA / NE / 5-HT transporters NNMT […]
For research use only. Not for human consumption
Vantage Aminos supplies research-grade peptides exclusively for laboratory and scientific research. You must be 21 or older and a qualified research professional to enter this site.
I am under 21, exit